课题基金 / 基金详情

宿主蛋白Sec61通过LMP1调控EB病毒复制的研究

批准号:
32070158
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
段子渊
学科分类:
病毒学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
段子渊

项目摘要

结项摘要

相似基金

相关文献

中文摘要
LMP1作为EB病毒的关键癌蛋白定位于细胞膜和质膜系统,具有信号转导和基因调控作用, 对EBV相关肿瘤发生至关重要。我们从LMP1与宿主相互作用蛋白的筛选入手,通过Co-IP-MS和Co-focal技术筛选并初步确认了与LMP1有相互作用的宿主分子Sec61,证明易感细胞接种EBV 后上调了Sec61的表达。Sec61是内质网中参与蛋白翻译及转运的重要成分,参与多种病毒的生命周期。本项目拟利用Co-IP、丙氨酸扫描、激光共聚焦、免疫印迹和3D活细胞成像示踪等技术,进一步确证LMP1和Sec61的相互作用,鉴定其互作关键区域和氨基酸位点;明晰Sec61调控LMP1胞内外转运影响EBV基因组稳定和病毒蛋白表达的通路;揭示Sec61通过调控LMP1的定位配置和功能发挥进而促进EBV复制的分子机制。本项目的完成有望对EBV潜伏感染机制提供新认识,并为EBV潜伏感染和相关疾病的治疗提供潜在新靶点。
英文摘要
The viral latent membrane protein 1 (LMP1),acting as a critical oncoprotein of EBV,is located in the cell membrane and plasma membrane system, plays the role of signal transduction and gene regulation during its infection and is essential for the occurrence of EBV-related human cancers. We started with screening of LMP1 interacting with host proteins, identified and confirmed that Sec61 is a novel LMP1-interacting host protein by immunoprecipitation combined with mass spectrum and with confocal laser scanning microscopy. Further, we have proved that the expression of Sec61 was up-regulated when EBV infected susceptible cells. Since Sec61 is an important component involved in protein translation and transportation in the endoplasmic reticulum, and participates in the life cycle of many viruses. This proposed project would to further verify the interaction of LMP1 and Sec61, and explore the key areas and nucleotide sites of the interaction region, to investigate the pathway that Sec61 regulates the intra- and extracellular transport of LMP1 and then affects the stability of EBV genome and viral protein expression, to elucidate the molecular mechanism that Sec61 promotes the replication of EBV by regulating the positioning and functional exertions of LMP1, through employing Co-IP, alanine scanning mutagenesis, confocal laser scanning microscopy, immunoblotting,3D live cell imaging tracing and other techniques. The completion of the project will expected to provide new understanding of the mechanism of EBV latent infection, and provide new potential targets for the treatment of EBV latent infection and related diseases.
EB病毒感染与多种癌症的发生密切相关。其中,潜伏膜蛋白LMP1是重要的致癌因子,定位于细胞膜和质膜系统,具有多种生物学功能,可调控EB病毒的感染和复制。此外,EB病毒miRNA参与病毒潜伏、免疫逃逸以及肿瘤形成过程的调控。因此,本项目主要:1)通过Co-IP-MS、Co-focal以及蛋白质免疫印迹等实验筛选了LMP1与Sec61相互作用结构域,进一步明确Sec61可促进EB病毒裂解复制;2)通过划痕、Transwell等实验发现EB病毒miR BART 14-3P抑制MIER3的3’非编码区活性,抑制MIER3蛋白表达,进而促进细胞增殖和迁移;3)EBV miRNA BART16抑制EB病毒引起的细胞增殖和迁移;4)初步发现黄酮类天然化合物可激活潜伏感染的EB病毒。本项目的完成不仅发现易位蛋白可调控EB病毒的裂解复制,也明晰miRNA参与调控EB病毒感染细胞的增殖和迁移作用,且发现黄酮类化合物-槲皮素可激活潜伏感染的EB病毒。本研究内容为EBV感染和相关疾病的治疗提供潜在新靶点。
国内基金
海外基金